Shoulder pain relief after rotator cuff surgery using nerve blocks
Shoulder Anterior Capsular Block Versus Combined Suprascapular and Axillary Nerve Blocks for Postoperative Analgesia in Arthroscopic Rotator Cuff Repair Surgery
This study is testing a new way to manage pain after rotator cuff surgery using specific nerve blocks to see if it helps patients feel better with fewer side effects.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 21 Years to 65 Years |
| Sex | All |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig, Al Sharqia) |
| Trial ID | NCT06969625 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of a shoulder anterior capsular block (SHAC) combined with suprascapular and axillary nerve blocks (SSNB-ANB) for managing postoperative pain in patients undergoing arthroscopic rotator cuff repair surgery. The study aims to provide effective analgesia while minimizing complications associated with traditional interscalene nerve blocks. By utilizing ultrasound guidance, the trial seeks to validate the SHAC block's efficacy in improving patient outcomes and satisfaction following surgery. The approach focuses on targeting the specific nerves that innervate the shoulder joint to enhance pain management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 21-60 who are undergoing arthroscopic rotator cuff repair surgery and have a physical status classified as ASA 1 or II.
Not a fit: Patients with contraindications to regional blocks, chronic opioid use, or significant comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve postoperative pain management and recovery for patients undergoing shoulder surgery.
How similar studies have performed: Previous studies have shown success with similar nerve block techniques, indicating potential for effective pain relief in shoulder surgeries.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients acceptance * Age: 21-60 years * Sex: both sexes (males or females). * Physical status: ASA 1\& II. * Body mass index (BMI) ≤ 30 kg/m2 * Type of operation: arthroscopic rotator cuff repair surgery. * Duration of surgery: within 2 hours. Exclusion Criteria: * Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site) * Patients with known history of allergy to the study drugs. * patients with neuropathy involving the limb undergoing surgery * Advanced hepatic, renal, cardiovascular, and neurologic diseases. * history of previous shoulder operation or fracture. * conversion to open surgery from arthroscopy. * pregnant females * patients with chronic opioid use
Where this trial is running
Zagazig, Al Sharqia
- Zagazig University Hospitals — Zagazig, Al Sharqia, Egypt (Recruiting)
Study contacts
- Principal investigator: Sherif M. S. Mowafy, MD — Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University
- Study coordinator: Sherif M. S. Mowafy, MD
- Email: sherifmowafy2012@gmail.com
- Phone: +201003523374
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.